20 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
to the procurement, labeling, storage, distribution, sale, importation, exportation, handling, quality, and safety, or promotion of any Product, and any ingredients … or to regulatory approvals, investigational exemptions, or the procurement, development, research, manufacture, production, packaging, labeling, distribution
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
and Imvexxy.
“Public Health Laws” means all Requirements of Law applicable to the business of the Company and relating to the procurement, development … . General Services Administration published list of parties excluded from federal procurement programs and non-procurement programs; or (z) to the knowledge
8-K
EX-10.1
bzxyjynf00tv0 hwjw
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.1
0m6vy3i 7yy3xt2i8ds
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.2
vmqe32w
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
ub7k35rps88 6h07o2
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-99.2
g98fm6sk
13 Aug 18
TherapeuticsMDAnnounces FDA Approval of ANNOVERA ™(Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control
6:01am
8-K/A
ztjq0w9 9rgqfpyi
22 Nov 11
Entry into a Material Definitive Agreement
12:00am
CORRESP
n1ipfno hx3e92gv
22 Nov 11
Correspondence with SEC
12:00am
- Prev
- 1
- Next